קומפיוג'ן תציג נתוני פעילות אנטי-סרטנית ובטיחות עבור השילוב של COM701, COM902 ו- Pembrolizumab בחולות עם סרטן שחלות עמיד לטיפולי פלטינום בכנס-SITC 202 false
קומפיוגן בע"מ 2 380
COMPUGEN LTD
Corporation no: 511779639 12833
Israel Securities Authority   Tel Aviv Stock Exchange   C002 ( Public )   Reported via MAGNA: 05/11/2024
  www.isa.gov.il     www.tase.co.il       Reference: 2024-02-613864 Time of broadcast: 11:26 11:26
The corporation scheduled the publication of the report to 05/11/2024 16:00
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

a2432222_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       
Stock Exchange/Market: TASE Date of revision of form structure: 06/08/2024
Address: Harokmim 26 , Holon 5885849   , Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
E-mail address: eranbd@cgen.com  

Previous names of reporting entity:

Name of the Signatory: Ben Dor Eran Position of Signatory in the reporting corporation: General Counsel & Corporate Secretary Name of Employer Company:
Address: Harokmim 26 , Holon 5885849 Telephone: 03-7658585 Facsimile: 03-7658555 E-mail: eranbd@cgen.com 1